Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-25-228339

Chief Medical Officer sold 12,039 shares at $14.58 ($175,518)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bedrosian Camille L Chief Medical Officer 2025-09-30 Sale −12,039 $14.58 $175,518 182,336 D: show line 1 in the form
Open-market sales · 12,039 sh · avg $14.58 · $175,518
Loading xslF345X05/ownership.xml…